Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the long-term safety of treating recurrent episodes
of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or
tinea cruris for 7 days for each recurrence with Product 33525.